Clinical Evidence for and Cost-Effectiveness of Advanced Cellular

     Tissue Products for the Treatment of Diabetic Foot Ulcers


In its recently released research compendium Diagnosis and Management of Diabetic Foot Complications, the American Diabetes Association (ADA) provides a comprehensive overview of the latest approaches for the manage- ment and treatment of DFUs and their complications. Produced by leading international DFU authorities, the compendium includes information about the use of adjunctive therapies, such as hyperbaric oxygen and negative pressure wound therapy, in instances in which DFUs do not respond to standard treatment.5 Among the treatments highlighted in the compendium that garnered the most attention were advanced cellular tissue products (CTPs). These are bioengineered cell-based therapies that supply the wound with the cells, tissues, proteins, and growth factors needed to support the healing process … read more (registration required)